1.1 C
New York
Wednesday, January 29, 2025

FDA Clears New Options in AI-Powered Mammography Software program Suite


A brand new model of an AI-enabled mammography software program might improve breast most cancers detection and bolster workflow effectivity for mammography evaluation.

Therapixel’s up to date MammoScreen suite has garnered new 510(ok) clearances for breast density analysis and new software program that gives quite a lot of options to assist cut back workflow bottlenecks for radiologists.

Therapixel’s up to date MammoScreen mammography suite garnered a brand new FDA 510(ok) clearance for breast density evaluation and clearance of latest software program, which incorporates automated pre-reporting that facilitates enhanced effectivity with reporting of mammography findings. (Picture courtesy of Therapixel.)

The corporate stated key options embody the power to prepare the day’s worklist by a case complexity index; an algorithm that facilitates evaluation of 2D and 3D breast imaging and a affected person’s prior historical past; and automatic pre-reporting that facilitates enhanced effectivity with reporting of mammography findings.

“With these new options, radiologists can double their studying time financial savings in comparison with the earlier model. Radiologists will respect the decreased fatigue, directors the improved effectivity and care consistency, and the IT staff the seamless one-time set up. We’re proud to launch this new model of MammoScreen, as soon as once more delivering unparalleled worth to radiologists and sufferers,” famous Matthieu Leclerc-Chalvet, the chief govt officer of Therapixel.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles